311
Views
2
CrossRef citations to date
0
Altmetric
Letters to the Editor

Impact of maintenance rituximab in patients with de novo transformed indolent B cell lymphoma

ORCID Icon, , , , , , , ORCID Icon, , , , , & show all
Pages 2985-2989 | Received 19 Jun 2020, Accepted 25 Jun 2020, Published online: 06 Jul 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Hideki Uryu, Yuko Mishima, Naoko Tsuyama, Masahiro Yokoyama, Noriko Nishimura, Takanori Fukuta, Yuko Shirouchi, Takashi Okabe, Norihito Inoue, Kengo Takeuchi & Yasuhito Terui. (2021) Rituximab maintenance improves outcomes of transformed diffuse large B-cell lymphoma: a retrospective study of 519 cases with de novo diffuse large B-cell lymphoma and 62 cases with concurrent diffuse large B-cell lymphoma and follicular lymphoma. Leukemia & Lymphoma 62:9, pages 2141-2150.
Read now

Articles from other publishers (1)

Zhe Wang, Wanting Ma, Xingxing Fu, Yanfei Qi, Yinan Zhao & Shubiao Zhang. (2023) Development and applications of mRNA treatment based on lipid nanoparticles. Biotechnology Advances 65, pages 108130.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.